Related Experiment Video
Updated: Dec 24, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Mn(ii) silver-aptamer clusters for targeted MR imaging of tumors
Wei-Yu Mu1, Xin-Xin Xiao, Tian-Tian Chen
1School of chemistry and chemical engineering, Jiangsu University, Zhenjiang, 212013, P. R. China. chemqy@ujs.edu.cn.
Abstract:
Hypoxia-inducible factor (HIF) highly expressed in most of the cancer cells. The Mn(ii)-aptamer based nanoclusters with 3D structures would be HIF-aptamer based targeted magnetic resonance imaging agents for cancer MRI diagnosis. Herein, a new class of contrast agent Mn(ii) silver-aptamer clusters (AdpaMn@DNA-Ag-DNAG1) were constructed based on the assembly of DNA-mediated Ag nanoclusters (DNA-AgNCs) with the Mn(ii) complex (AdpaMn) and DNAG1, the recognition sequence of GLUT-1. Then, the Mn(ii) silver-aptamer clusters (AdpaMn@DNA-Ag-DNAG1) are used as the MRI agents both in vitro and in vivo. The results show that the MRI signal is clearly presented in the tumor position. Consequently, the Mn(ii) silver-aptamer clusters can be used as a new class of contrast agents for targeted MR imaging of tumors.

